Wird geladen...

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma

Feline mammary carcinoma (FMC) is a common neoplasia in cat, being HER2-positive the most prevalent subtype. In woman’s breast cancer, tyrosine kinase inhibitors (TKi) are used as a therapeutic option, by blocking the phosphorylation of the HER2 tyrosine kinase domain. Moreover, clinical trials demo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutics
Hauptverfasser: Gameiro, Andreia, Almeida, Filipe, Nascimento, Catarina, Correia, Jorge, Ferreira, Fernando
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002158/
https://ncbi.nlm.nih.gov/pubmed/33800900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030346
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!